Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting

Abstract Objective Ondansetron orally soluble pellicle can serve as an alternative option for preventing nausea and vomiting in patients who receive chemotherapy. However, there is a lack of clinical evidence regarding ondansetron. This study aimed to explore the efficacy and safety of ondansetron i...

全面介紹

書目詳細資料

發表在:	BMC Cancer
Main Authors:	Lu Sun, Jia Ma, Yajuan Zhou, Xiaofang Ying, Gai Liang, Guoliang Pi, Ying Li, Yan Luo, Jianping Bi, Hanping He, Yi Peng
格式:	Article
語言:	英语
出版:	BMC 2025-01-01
主題:	Ondansetron orally soluble pellicle Moderate-to-high emetic risk chemotherapy Nausea and vomiting Efficacy Safety
在線閱讀:	https://doi.org/10.1186/s12885-024-13406-z